CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signalingTao Wang(Huazhong University of Science and Technology), Ke Chen(Huazhong University of Science and Technology)OncotargetSeptember 25, 201410.18632/oncotarget.2511Cited by 66SaveCiteExport RISWatch citationsRelated PapersFlightless I Homolog Reverses Neo-Endocrine Therapy Resistance through YBX1/PD-L1 Axis Mediated-Immune Evasion in Prostate Cancer|Research Square|2020|1